Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mersana Therapeutics Inc.

0.3977
-0.0023-0.57%
Post-market: 0.3878-0.0099-2.49%19:29 EDT
Volume:1.57M
Turnover:606.55K
Market Cap:49.57M
PE:-0.70
High:0.4099
Open:0.4067
Low:0.3751
Close:0.4000
Loading ...
Feb 28, 2022

Major Issues Report

8-K - Current report
Feb 17, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 04, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 03, 2022

Major Issues Report

8-K - Current report
Jan 03, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 23, 2021

Major Issues Report

8-K - Current report
Nov 16, 2021

Correspondence

CORRESP [Cover] - Correspondence
Nov 09, 2021

Major Issues Report

8-K - Current report
Nov 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 29, 2021

Major Issues Report

8-K - Current report
Sep 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 10, 2021

Major Issues Report

8-K - Current report
Aug 16, 2021

Major Issues Report

8-K - Current report
Aug 06, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2021

Major Issues Report

8-K - Current report
Jun 17, 2021

Major Issues Report

8-K - Current report
May 10, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]